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Available online 17 July 2006Prion (PrP) and amyloid-β (Aβ) peptides are involved in the neuronal
loss that occurs in Prion disorders (PrD) and Alzheimer's disease
(AD), respectively, partially due to Ca2+ dysregulation. Besides, the
endoplasmic reticulum (ER) stress has an active role in the neurotoxic
mechanisms that lead to these pathologies. Here, we analyzed whether
the ER-mediated apoptotic pathway is involved in the toxic effect of
synthetic PrP and Aβ peptides. In PrP106–126- and Aβ1–40-treated
cortical neurons, the release of Ca2+ through ER ryanodine (RyR) and
inositol 1,4,5-trisphosphate (IP3R) receptors induces ER stress and
leads to increased cytosolic Ca2+ and reactive oxygen species (ROS)
levels and subsequently to apoptotic death involving mitochondrial
cytochrome c release and caspases activation. These results demon-
strate that the early PrP- and Aβ-induced perturbation of ER Ca2+
homeostasis is a death message that leads to neuronal loss, suggesting
that the regulation of ER Ca2+ levels may be a potential therapeutical
target for PrD and AD.
© 2006 Elsevier Inc. All rights reserved.
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stressIntroduction
Prion disorders (PrD) and Alzheimer's disease (AD) are
progressive neurodegenerative diseases characterized by neuronal
loss, cognitive dysfunction and dementia. These diseases are linked
by the extracellular deposition of the scrapie isoform of prion
protein (PrPSc) and the amyloid-beta protein (Aβ), respectivelyAbbreviations: Aβ, amyloid-beta peptide; PrP, prion peptide; AD,
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RyR, ryanodine receptor.
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doi:10.1016/j.nbd.2006.05.011(Prusiner, 1996; Wisniewski et al., 1997). In PrD, the PrPSc results
from the conversion of the normal protein PrPC, is insoluble in
nondenaturating detergents, aggregates easily and is partially
resistant to protease digestion. The PrP106–126, a synthetic
peptide homologous to PrPSc, has been used as a model system
to study prion-induced neurodegeneration (Della-Bianca et al.,
2001; Pérez et al., 2003). PrP106–126 is rich in β-sheet structure,
forms aggregates that are detergent-insoluble and PK-resistant and
catalyzes the aggregation of endogenous PrPC to an amyloidogenic
form that shares several characteristics with PrPSc (Ettaiche et al.,
2000; Brown, 2000; Singh et al., 2000). In AD, the amyloidogenic
material is composed of amyloid-beta peptide (Aβ), derived from
β- and γ-secretases cleavage of amyloid precursor protein (APP) in
the endoplasmic reticulum (ER), the Golgi apparatus or the
endosomal–lysosomal pathway, and most is normally secreted as a
1–40 (Aβ1–40) or 1–42 (Aβ1–42) amino acid peptide (Perez et al.,
1999). Synthetic Aβ1–40 and Aβ1–42 are amyloidogenic and
neurotoxic peptides that have been widely used to mimic in vitro
the degenerative process that occurs in the brain of AD patients
(Mattson, 1997; Pereira et al., 1999).
The ER is an essential intracellular organelle involved in
intracellular calcium homeostasis, in folding and processing of
proteins and in cell death activation (Baumann and Walz, 2001).
Ca2+ release from the ER is mediated through ryanodine receptors
(RyR) and inositol 1,4,5-triphosphate receptors (IP3R) (Berridge et
al., 2000). Changes in ER Ca2+ homeostasis induce the accumula-
tion of unfolded proteins and activate the ER-stress-induced
apoptosis pathway (Kaufman, 1999; Pashen, 2001). In response to
ER stress, expression of glucose-regulated protein (GRP) 78, an
ER chaperone, is induced (Kaufman, 1999; Rao et al., 2002).
Furthermore, caspase-12, that is mainly located on the cytoplasmic
side of the ER, is activated (Nakagawa et al., 2000; Nakagawa and
Yuan, 2000) and can further activate caspase-9 and -3 (Morishima
et al., 2002).
It was recently shown that caspase-12 knock-out mice are
resistant to ER stress and to death caused by Aβ protein (Nakagawa
et al., 2000) and also that caspase-12 activation and increased
expression of GRP58, a chaperone with (PDI)-like activity, occur
in cells treated with PrPSc (Hetz et al., 2003, 2005). These results
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that occurs in PrD and AD. In vitro studies have suggested that ER
Ca2+ dyshomeostasis and oxidative stress are synergistically
related. While ER function is sensitive to the presence of oxidants
(Dreher et al., 1995; Racay et al., 1995; Viner et al., 1996; Hayashi
et al., 2005), reactive oxygen species (ROS) can also be produced
intracellularly from the stress-regulated release of calcium from the
ER. This calcium is readily taken up by mitochondria, resulting in
the elevation of ROS (Tardif et al., 2005).
The purpose of the present study was to elucidate the role of
ER-mediated apoptotic pathway in the neurotoxic effects induced
by PrP106–126 and Aβ1–40. Our results suggest that, in ER, the
early Ca2+ release through the RyR and IP3R, induced by these
peptides, is involved in the perturbation of Ca2+ homeostasis and
ROS production, leading to cytochrome c release and caspase-3
activation and finally to apoptotic cell death. These findings give a
contribution to the elucidation of the mechanism of neuronal death
that occurs in PrD and AD.
Materials and methods
Materials
Neurobasal medium and B27 supplement were purchased from
Gibco BRL, Life Technologies (Scotland, UK). Trypsin, deoxyr-
ibonuclease I (DNase I), trypsin inhibitor type II-S-soybean,
protease inhibitors, phenylmethylsulfonyl fluoride (PMSF), bovine
serum albumin (BSA), dantrolene and thapsigargin were obtained
from Sigma Chemical Co. (St. Louis, MO, USA). SYTO-13,
propidium iodide (PI), Indo-1 acetoxymethyl ester (Indo-1/AM),
2′,7′-dichlorodihydrofluorescein diacetate (DCFH2-DA), Mito-
Tracker Green, Hoechst 33342 and Alexa Fluor 594 goat anti-
mouse IgG conjugate were purchased from Molecular Probes
(Leiden, Netherlands). The synthetic Aβ1–40, Aβ40–1, PrP106–
126 and PrPscrambled peptides were from Bachem (Bubendorf,
Switzerland). Ionomycin and xestospongin C were purchased from
Calbiochem (Darmstadt, Germany). The colorimetric substrates for
caspase-2 [N-acetyl-Val-Asp-Val-Ala-Asp-P-nitroanilide (Ac-
VDVAD-pNA)], caspase-6 [N-acetyl-Val-Glu-Ile-Asp-P-nitroani-
lide (Ac-VEID-pNA)] and caspase-9 [N-acetyl-Leu-Glu-His-Asp-
P-nitroanilide (Ac-LEHD-pNA)] were obtained from BioSource
International (Nivelles, Belgium), whereas the substrate for
caspase-3 [N-acetyl-Asp-Glu-Val-Asp-P-nitroanilide (DEVD-
pNA)] was from Calbiochem (Darmstadt, Germany) and for
caspase-8 [N-acetyl-Ile-Glu-Thr-Asp-P-nitroanilide (Ac-IETD-
pNA)] was from Sigma Chemical Co. (St. Louis, MO, USA).
Bio-Rad protein dye assay, reagents and apparatus used in
immunoblotting assays were purchased from Bio-Rad (Hercules,
CA, USA). The following primary antibodies were from BD
Pharmingen (San Diego, CA, USA): monoclonal mouse anti-BiP/
Grp78, monoclonal mouse reactive against the native form of
cytochrome c and polyclonal rabbit anti-caspase-12. The mono-
clonal mouse anti-microtubule-associated protein 2 (MAP2) and
the rabbit anti-glial fibrillary acidic protein (GFAP) antibody were
purchased from Sigma Chemical Co. (St. Louis, MO, USA). The
goat anti-rabbit IgG and goat anti-mouse IgG antibodies
conjugated to alkaline phosphatase, the enhanced chemiFluores-
cence reagent (ECF) and the polyvinylidene difluoride (PVDF)
membrane were obtained from Amersham Pharmacia Biotech
(Buckinghamshire, UK). The DakoCytomation Fluorescent mount-
ing medium was purchased from DakoCytomation (Carpinteria,California, USA). All the other chemicals were obtained from
Sigma (St. Louis, MO, USA) or from Merck kgaA (Darmstadt,
Germany).
Primary cortical neuronal cultures and experimental treatments
Primary cultures of cortical neurons were prepared from 15 to
16 days embryos of Wistar rats according to the method described
by Hertz et al. (1989), with some modifications (Agostinho and
Oliveira, 2003). Briefly, removed cortices were dissected and
placed in Ca2+- and Mg2+-free Krebs buffer (in mM): NaCl 120,
KCl 4.8, KH2PO4 1.2, glucose 13 and HEPES 10 (pH 7.4)
supplemented with BSA (0.3 mg/ml). Minced cortical tissues were
washed and incubated in Krebs solution supplemented with BSA,
and containing trypsin (0.5 mg/ml) and DNase I (0.04 mg/ml), for
10 min at 37°C. The digestion was stopped with Krebs buffer
containing trypsin inhibitor (type II-S) (0.75 mg/ml) and DNase I
(0.04 mg/ml) followed by a centrifugation at 140 × g for 5 min.
After washing the pellet once with Krebs buffer, the cells were
resuspended in fresh Neurobasal medium supplemented with 2 mM
L-glutamine, 2% B27 supplement, penicillin (100 U/ml) and
streptomycin (100 μg/ml) and were dissociated mechanically.
Cortical cells were plated on poly-L-lysine (0.1 mg/ml)-coated
glass coverslips at a density of 0.10 × 106 cells/cm2 for
immunocytochemistry experiments and nuclear morphology stu-
dies or 0.40 × 106 cells/cm2 for measurement of intracellular Ca2+
or ROS levels. For caspase-like activity assays and immunoblot-
ting, neurons were mounted on poly-L-lysine (0.1 mg/ml)-coated
dishes at a density of 0.45 × 106 cells/cm2. The cultures were
maintained at 37°C in a humidified atmosphere of 5% CO2/95% air
and were used for experiments after 5 to 7 days in vitro.
Differentiated cortical neurons were treated with Aβ1–40 or Aβ40–
1 (0.5 μM) or with PrP106–126 or PrPscrambled (25 μM) in
serum-free Neurobasal medium supplemented with B27. PrP
peptides were added from a stock solution prepared in sterile
distilled water, at a concentration of 1 mM. Aβ peptides were
dissolved in sterile distilled water at a concentration of 6 mg/ml
and diluted to 1 mg/ml (231.5 μM) with phosphate saline buffer
(PBS) and then incubated for 5–7 days to induce fibril formation.
The concentrations of Aβ1−40 and PrP106–126 used were chosen
based on previous results demonstrating that, on cortical neurons,
0.5 μM Aβ1–40 and 25 μM PrP106–126 induced a maximal toxic
effect (50% decrease in cell viability). Before the addition of Aβ1–
40 or PrP106–126, cells were preincubated for 1 h with dantrolene
(10 μM) or xestospongin C (1 μM), concentrations that were
shown to exert a maximal protective effect, without being toxic by
itself (data not shown).
Assessment of neuronal injury
After treatment of cortical cells with Aβ1–40 or PrP106–126,
neuronal injury was assessed as described in Ferreiro et al. (2004).
Reverse Aβ1–40 (Aβ40–1) or scrambled PrP was also used in
order to analyze the specificity of the amino acids sequence of both
peptides. Neurons were stained with PI (2.5 μg/ml) and SYTO-13
(3.8 μM), and the nuclear morphology was analyzed by
fluorescence microscopy. Cortical cells cultured on glass coverslips
were treated with Aβ1–40 or PrP106–126, in the absence or in the
presence of dantrolene or xestospongin C. Cells were examined
and scored with a Nikon Diaphot TMP microscope, using a triple
XF-63 Omega filter. All experiments were performed in duplicate,
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number of viable, necrotic and apoptotic cells was expressed as the
percentage (%) of the total number of cells in the microscope field.
Measurement of intracellular Ca2+ concentration
Cortical cells cultured on glass coverslips, in the presence or in
the absence of peptides, were incubated in the dark with 3 μM
Indo-1/AM in a salt solution without phosphate containing (in
mM): NaCl 132, KCl 4, CaCl2 1, MgCl2 1.4, glucose 6, HEPES–
Na 10, pH 7.4 for 45 min at 37°C. The cells were further
incubated, for 15 min, in the absence of Indo-1/AM, to ensure a
complete hydrolysis of the acetoxymethyl ester of Indo-1. After
washing, cells were mounted in a special holder, and the Indo-1
fluorescence was measured with excitation wavelength of 335 nm
and 410 nm emission. The free intracellular Ca2+ concentration
([Ca2+]i) was calculated as previously described (Bandeira-Duarte
et al., 1990).
Caspases activity assay
Untreated or treated cortical cells were lysed with a buffer
containing (in mM): HEPES–Na 25, MgCl2 2, EDTA 1, EGTA 1
supplemented with 100 μM phenylmethylsulphonyl fluoride
(PMSF), 2 mM DTT and a protease inhibitor cocktail (containing
1 μg/ml leupeptin, pepstatin A, chymostatin and antipain). The
cellular suspension was rapidly frozen/defrosted three times and
then centrifuged for 10 min at 20,200 × g. The supernatant was
collected and assayed for protein content using the Bio-Rad protein
dye assay reagent. To measure caspases activity, aliquots of cell
extracts containing 25 μg or 40 μg of protein were incubated for
2 h at 37°C, in a reaction buffer containing 25 mM HEPES–Na,
10 mM DTT, 10% sucrose and 0.1% CHAPS (pH 7.4) with
100 μM Ac-VDVAD-pNA, Ac-DEVD-pNA, Ac-VEID-pNA, Ac-
IETD-pNA or Ac-LEHD-pNA, chromogenic substrates for
caspase-2, -3, -6, -8 and -9, respectively (Cregan et al., 1999).
Caspases activity was determined by measuring substrate cleavage
at 405 nm using a microplater reader, and results were expressed as
the increase above control absorbance at 405 nm.
Western blotting analysis
For the preparation of total cell extracts, cells which were either
treated or untreated with the peptides were scraped in Neurobasal
medium and centrifuged at 140×g. The pellet was resuspended in
200 μl of ice-cold lysis buffer containing (in mM): HEPES–Na 25,
MgCl2 2, EDTA 1, EGTA 1, supplemented with 100 μM PMSF,
2 mM DTT and protease inhibitor cocktail (containing 1 μg/ml
leupeptin, pepstatin A, chymostatin and antipain). Cell lysates
were frozen three times in liquid N2 and were centrifuged at 140 × g
to remove nuclei and large debris. Protein concentration in the
supernatant was measured using the Bio-Rad protein dye assay
reagent. Samples were denaturated at 95°C for 3 min in a 6×
concentrated sample buffer (mM): Tris 500, DTT 600, 10.3%
SDS, 30% glycerol and 0.012% bromophenol blue. Equal amount
of each sample of protein was separated by electrophoresis on a
10% SDS-polyacrylamide gels (SDS-PAGE) and electroblotted
onto PVDF membranes. The identification of proteins of interest
was facilitated by the usage of a prestained precision protein
standard (Bio-Rad) which was run simultaneously. After the
proteins were electrophoretically transferred, the membranes wereincubated for 1 h at room temperature (RT) in Tris buffer (mM;
NaCl 150, Tris–HCl 25 (pH 7.6) with 0.1% Tween 20 (TBS-T)
containing 5% nonfat dry milk) to eliminate nonspecific binding,
and were next incubated overnight at 4°C in TBS-T containing
1% nonfat dry milk with a rabbit polyclonal primary antibody
against caspase-12 (1:1000 dilution) or a mouse monoclonal
primary antibody against GRP78 (1:250 dilution). The mem-
branes were washed several times and then incubated in TBS-T
with 1% nonfat dry milk for 2 h at RT, with the appropriate
alkaline-phosphatase-conjugated anti-rabbit or anti-mouse second-
ary antibody at a dilution of 1:25,000 or 1:20,000, respectively.
Immunoreactive bands were detected after incubation of mem-
branes with ECF reagent for 5–10 min, on a Bio-Rad Versa Doc
3000 Imaging System.
Immunocytochemistry
Control, Aβ1–40- or PrP106–126-treated cells were washed
two times in PBS buffer (pH 7.4) and were fixed with 4%
paraformaldehyde for 30 min at RT. For cytochrome c release
experiments, cells were incubated with 750 nM MitoTracker Green
for 45 min at 37°C, in the dark. Then, the cells were permeabilized
for 2 min at RTwith 0.2% Triton-X100 in PBS buffer (pH 7.4), and
the nonspecific binding sites were blocked for 30 min at RT in PBS
containing 3% BSA. Cells were incubated for 1 h with a mouse
monoclonal anti-cyt c antibody that recognizes the native form of
the protein (1:100 dilution), or with a mouse monoclonal anti-
MAP2 (1:500 dilution) and a rabbit monoclonal anti-GFAP
antibody (1:200 dilution), prepared in PBS containing 3% of
BSA and incubated with Alexa Fluor 594 goat anti-mouse IgG
antibody conjugated (1:100 dilution in 3% BSA/PBS) or with
Alexa Fluor 488 goat anti-rabbit IgG antibody conjugated (1:100
dilution in 3% BSA/PBS) for 1 h at RT. Cells labeled with anti-
MAP2 and anti-GFAP were also incubated with Hoechst 33342
(15 μg/ml dilution in PBS). Finally, the cells were washed and
treated with DakoCytomation Fluorescent mounting solution on a
microscope slide, and neurons were visualized in a confocal
microscope (Bio-Rad MRC 600, Cambridge, MA, UK) or in an
Axiovert 200 fluorescence microscope (Zeiss, Germany).
Measurement of intracellular reactive oxygen species
The levels of ROS, in particular of intracellular hydroperoxides,
were assessed using the oxidant-sensitive dye 2′,7′-dichlorodihy-
drofluorescin diacetate (DCFH2-DA), a cell-permeant nonfluor-
escent compound that is converted to the acid 2′,7′-
dichlorodihydrofluorescin (DCFH2) when the acetate groups are
removed by intracellular esterases. This ionized acid is trapped into
the cells and can be oxidized to fluorescent 2′,7′-dichlorofluorescin
(DCF) (Cathcart et al., 1993). Control cells treated with Aβ1–40 or
PrP106–126 were incubated with 5 μM DCFH2-DA in sodium
medium for 20 min at 37°C. After DCFH2-DA incubation, cells
were washed and further incubated in sodium medium for 10 min
to allow its desterification. Then, the glass coverslips containing
the loaded cells were mounted in a special holder (Perkin-Elmer
L225008) and placed inside a temperature-controlled (37°C)
cuvette containing sodium medium, with an alignment of 60° to
the excitation beam (to minimize the effect of light reflection). The
fluorescence signals, corresponding to intracellular ROS, were
monitored for 30 min at 502 nm excitation and 550 nm emission,
using a temperature-controlled SPEX Fluorolog spectrometer.
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Results are expressed as means ± SEM of the number of
experiments indicated in the figure captions. Statistical significance
was performed using an analysis of variance (ANOVA) followed
by Dunnett's post hoc tests for multiple comparisons or by the
unpaired two-tailed Student's t test. A P < 0.05 value was
considered statistically significant.Fig. 2. PrP106–126 and Aβ1–40 induce the increase of Grp78 levels andResults
Cortical neurons used throughout this work were cultured in
serum-free Neurobasal medium in the presence of B27 supplement,
which supports growth of neurons and minimizes glial cell
proliferation. The purity of neuronal cultures was confirmed by
immunocytochemistry using the neuronal marker microtubule-
associated protein 2 (MAP-2) antibody and the anti-glial fibrillary
acidic protein (GFAP) antibody, a marker of astrocytic proliferation
(Fig. 1A). Quantification of MAP-2- and GFAP-positive cells
demonstrated that, under our experimental conditions, ~94% of the
cells in culture were neurons (Fig. 1B). Therefore, due to the reduced
number of astrocytes in the cultures used in this study (less than
10%), the effects observed could be attributed solely to neurons.
PrP106–126 and Aβ1–40 increase the levels of ER stress markers
To evaluate whether ER stress is induced in cortical neurons by
PrP106–126 and Aβ1–40 peptides, the levels of two known ER
stress markers, Grp78 and caspase-12 (Rao et al., 2002; Nakagawa
and Yuan, 2000), were analyzed by Western blotting. Treatment of
cortical neurons with PrP106–126 (25 μM) or Aβ1–40 (0.5 μM)
induces a significant increase in Grp78 levels at 6 h which persists
at 24 h of incubation, when compared with untreated cells (Fig.
2A). Furthermore, the decrease of the pro-caspase-12 levels in
treated cortical neurons suggests that PrP106–126 and Aβ1–40
lead to the activation of caspase-12. After exposure of cells to the
synthetic peptides, during 6 or 24 h, the pro-caspase-12 levelsFig. 1. Relative proportion of neurons and astrocytes in cortical cultures. (A)
Representative image of cortical cells labeled with the neuronal marker
microtubule-associated protein 2 (MAP-2) antibody (red) and the anti-glial
fibrillary acidic protein (GFAP) antibody, a marker of astrocytic proliferation
(green). Nucleus was stained with Hoechst 33342 (blue) (magnification
400×). (B) Quantification of the relative proportion of neurons and
astrocytes. (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
caspase-12 activation. Total cell extracts were obtained from cortical
neurons treated with PrP106–126 (25 μM) or Aβ1–40 (0.5 μM), for 6 h or
24 h, and the levels of Grp78 (A) and pro-caspase-12 (B) were determined
by Western blotting. To determine the significance of the differences in
expression level, data from at least three different experiments were
analyzed by densitometry (Graphs). Data were expressed as the
mean ± SEM. *P < 0.5; **P < 0.01; ***P < 0.001 with respect to control
values.decreased significantly (Fig. 2B). These results indicate that
PrP106–126 and Aβ1–40 induce ER stress and caspase-12
activation in cortical neurons.Cortical neurons treated with PrP106–126 and Aβ1–40 have high
intracellular Ca2+ levels. ER Ca2+ release contributes to perturbed
Ca2+ homeostasis
ER stress and caspase-12 activation can be mediated by Ca2+
signaling (Ferri and Kroemer, 2000), and therefore we analyzed
if under our conditions Ca2+ homeostasis was perturbed. We
also analyzed the contribution of ER Ca2+ release by the
determination of intracellular Ca2+ levels in the presence or
absence of dantrolene and xestospongin C, inhibitors of RyR
Fig. 3. Effect of PrP106–126 and Aβ1–40 on basal intracellular Ca2+ levels
in cortical neurons. (A) Cells were treated with PrP106–126 (25 μM) or
Aβ1–40 (0.5 μM) for 1 to 48 h. (B) Cortical neurons were incubated with
PrP106–126 (25 μM) or Aβ1–40 (0.5 μM) for 1 h, in the absence or in the
presence of dantrolene (10 μM) or xestospongin C (1 μM). The fluorescence
of Indo-1 loaded cells was measured, and the [Ca2+]i was calculated as
described in the Materials and methods section. The results are the
means ± SEM of values corresponding at least 3 experiments, each value
being the mean of duplicate assays. ***P < 0.001 with respect to control
values. ##P < 0.01 with respect to PrP and Aβ addition.
Fig. 4. PrP106–126 and Aβ1–40 induce the increase in intracellular reactive
oxygen species (ROS) levels. Dantrolene and xestospongin C protected
against intracellular ROS increase induced by PrP106–126 and Aβ1–40.
(A) Cortical neurons were treated with PrP106–126 (25 μM) or Aβ1–40
(0.5 μM) for 1 to 48 h. (B) Cortical neurons were incubated with PrP106–
126 (25 μM) for 3 h, in the absence or in the presence of dantrolene (10 μM)
or xestospongin C (1 μM). (C) Cortical neurons were incubated with Aβ1–
40 (0.5 μM) for 1 h, in the absence or in the presence of dantrolene (10 μM)
or xestospongin C (1 μM). Intracelullar ROS levels were determined by
DCF fluorescence. The results are the means ± SEM of values corresponding
at least 3 experiments, each value being the mean of duplicate assays.
***P < 0.001 with respect to control values. #P < 0.05; ##P < 0.01 with
respect to PrP and Aβ addition.
673E. Ferreiro et al. / Neurobiology of Disease 23 (2006) 669–678and IP3R, respectively. PrP106–126 and Aβ1–40 induce a
sustained increase of intracellular Ca2+ levels, starting at 1 h
until 48 h of incubation, when compared with the control (Fig.
3A). Since PrP106–126 and Aβ1–40 induce a significant
increase of intracellular Ca2+ levels at 1 h, we analyzed the
contribution of ER Ca2+ release through RyR and IP3R at this
incubation time. When co-incubated with PrP106–126 and Aβ1–
40, dantrolene (10 μM) or xestospongin C (1 μM) is protective
as demonstrated by the decrease in intracellular Ca2+ concentra-
tion to values similar to the control (Fig. 3B). Dantrolene and
xestospongin C alone have no effect in intracellular Ca2+ levels
of cortical neurons. These results show that PrP106–126 and
Aβ1–40 induce an early increase of intracellular Ca2+ levels due
to the release of Ca2+ from ER through RyR and IP3R, leading
to the consequent perturbation of Ca2+ homeostasis. The reverse
Aβ40–1 and the scrambled PrP peptides did not lead to any
significant increase in the intracellular Ca2+ levels (at 1 and
48 h), demonstrating that the specific sequence of amino acids
of Aβ and PrP peptides is needed for the perturbation of Ca2+
homeostasis (Figs. 3A and B).PrP106–126 and Aβ1–40 induce the increase of reactive oxygen
species mediated by ER Ca2+ release
Several studies suggest that, altogether with the changes in
calcium dynamics, abnormalities in oxidative stress are central to
the toxic effects of PrP106–126 and Aβ1–40 (Gibson, 2002;
O'Donavan et al., 2003; Agostinho and Oliveira, 2003). In order to
analyze the role of ER Ca2+ release in oxidative stress induced by
these amyloidogenic peptides, the production of reactive oxygen
species (ROS) was determined. PrP106–126 induces a time-
dependent increase in intracellular ROS levels that goes from 3 h to
24 h of incubation, decreasing at 48 h (Fig. 4A). At 1 h, PrP106–
126 has no significant effect on intracellular ROS levels. On the
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1 h, maintaining these levels until 48 h of incubation (Fig. 4A).
When cortical cells were treated for 3 h with PrP106–126 or for 1 h
with Aβ1–40, in the presence of dantrolene or xestospongin C, a
significant decrease in ROS levels is observed, demonstrating that
RyR- and IP3R-mediated ER Ca
2+ release is involved in oxidative
stress triggered by PrP and Aβ peptides in cortical neurons (Figs.
4B and C). Dantrolene or xestospongin C per se did not affect
intracellular ROS levels (data not shown).
PrP106–126 and Aβ1–40 induce cytochrome c release and
caspase-2, -3, -6, -8 and -9 activation upon ER Ca2+ release
The release of cytochrome c from mitochondria in cortical
neurons treated with PrP106–126 or Aβ1–40 was analyzed by
confocal microscopy determining the co-localization of the
mitochondrial fluorescent marker MitoTracker Green and an anti-
cytochrome c antibody. The involvement of ER Ca2+ release was
evaluated co-treating cells with PrP or Aβ peptides and the ER Ca2+
channels inhibitors dantrolene and xestospongin C. After 6 h of
treatment with PrP106–126 and Aβ1–40, a reduction in the overlay
of MitoTracker Green and anti-cytochrome c fluorescence isFig. 5. PrP106–126 and Aβ1–40 induce cytochrome c release from mitochondri
induce by PrP and Aβ peptides. Cortical neurons were treated for 6 h with PrP1
dantrolene (10 μM) or xestospongin C (1 μM). Cytochrome c localization was eval
labeled with anti-cyt c and MitoTracker green. Merged images provide evidence ab
of fluorescence (yellow-orange) indicates retention of cyt c in mitochondria. (For
referred to the web version of this article.)observed when compared with the control (Fig. 5). When cells
treated with PrP and Aβ were preincubated with dantrolene or
xestospongin C, the co-localization of cytochrome c with the
mitochondria was observed, as in the control cells, suggesting the
involvement of ER Ca2+ in cytochrome c release from mitochondria
induced by both peptides. Similar results were obtained in cells
treated with PrP106–126 and Aβ1–40 for 24 h (data not shown).
Cytochrome c release from the intermembrane space of
mitochondria is one of the triggers of the activation of several
caspases and apoptosis (Desagher and Martinou, 2000). Therefore,
we determined the activity of caspase-2, -3, -6, -8 and -9 upon
PrP106–126 or Aβ1–40 treatment. In cortical cells incubated with
PrP106–126 and Aβ1–40 for 48 h, the activation of caspase-2, -3,
-6, -8 and -9 was demonstrated, the most significant increase being
observed for caspase-6 (Fig. 6A).
Because caspase-3 is a key executioner of apoptosis (Kilic et al.,
2002), the protective effect of dantrolene and xestospongin C against
PrP- and Aβ-induced caspase-3 activation was analyzed. As shown
in Fig. 6B, when cortical cells are preincubated with the Ca2+
channel inhibitors dantrolene or xestospongin C, before PrP106–
126 treatment, the caspase-3 activation induced by the PrP peptide is
significantly reduced. Similar results were obtained in cells treateda. Ca2+ release through RyR and IP3R is involved in cytochrome c release
06–126 (25 μM) or Aβ1–40 (0.5 μM), in the absence or the presence of
uated by immunocytochemistry, using a confocal microscope. Cells were co-
out the co-localization of cyt c immunoreactivity with mitochondria. Overlay
interpretation of the references to colour in this figure legend, the reader is
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Treatment of cortical cells with dantrolene or xestospongin C for
48 h did not significantly affect the caspase-3-like activity (Fig. 6B).
Blockage of ER Ca2+ release protects against PrP106–126- and
Aβ1–40-induced increase in the number of apoptotic cells
In cortical neurons, apoptotic cell death upon exposure to PrP
and Aβ peptides was analyzed by fluorescence microscopy after
SYTO-13/PI labeling. Fig. 7A depicts that PrP106–126 and Aβ1–
40 significantly increase the number of apoptotic cells after 24 and
48 h of incubation. The most prominent effect on apoptotic death,
observed 48 h after addition of PrP and Aβ to cortical neurons, was
prevented by preincubation with dantrolene and xestospongin C
(Fig. 7B). Dantrolene and xestospongin C alone did not affect the
number of apoptotic cells. Results show that the appearance of
neurons with apoptotic morphology, upon exposure to PrP and AβFig. 6. Caspases activation in cortical neurons induced by PrP106–126 and
Aβ1–40. Effect of dantrolene and xestospongin C on the increase of
caspase-3-like activity induced by PrP and Aβ peptides. (A) Cells were
incubated for 48 h with PrP106–126 (25 μM) or Aβ1–40 (0.5 μM), and
caspase-2, -3, -6, -8 and -9 activity was determined. (B) Cells were incubated
for 48 h with PrP106–126 (25 μM) or Aβ1–40 (0.5 μM), in the absence or
the presence of dantrolene (10 μM) or xestospongin C (1 μM), and caspase-3
activity was determined. Caspase activity was determined using protein
extracts from cortical cells, and the activity measured by the quantity of
chromogenic substrates cleavage at 405 nm, as described in the Materials
and methods section. The results, expressed as the increase above control
values, are the means ± SEM of values corresponding at least to 3
experiments, each value being the mean of duplicate assays. ***P < 0.001
with respect to control values. ###P < 0.05 with respect to PrP or Aβ
addition.
Fig. 7. DNA fragmentation induced by PrP106–126 and Aβ1–40. (A) The
number of apoptotic cells induced by 25 μM PrP106–126 or 0.5 μM Aβ1–
40 for 24 and 48 h was determined by SYTO-13 and PI staining, as
described in the Materials and methods section. (B) Neurons were incubated
with PrP106–126 (25 μM) or Aβ1–40 (0.5 μM) for 48 h in the absence or
the presence of dantrolene (10 μM) or xestospongin C (1 μM). The results,
expressed as the percentage of the total number of cells, are the
means ± SEM of values corresponding at least to 3 experiments, each
value being the mean of duplicate assays.*P < 0.05; ***P < 0.001 with
respect to control values. ###P < 0.001 with respect to PrP or Aβ addition.peptides, can be prevented by the inhibition of Ca2+ release
through ER channels. The reverse Aβ40–1 and the scrambled PrP
peptides were not toxic to cortical neurons (Fig. 7B).Discussion
In the present study, we show that treatment of cortical neurons
with PrP106–126 or Aβ1–40 induces ER stress. This is
accompanied by a significant increase in the [Ca2+]i and in the
levels of ROS, cytochrome c release from mitochondria and
activation of several caspases including caspase-2, -3, -6, -8 and -9,
which culminates in apoptotic cell death. These parameters were
shown to be prevented by dantrolene and xestospongin C,
inhibitors of the ER Ca2+ release through RyR and IP3R,
demonstrating that the ER Ca2+ release through RyR and IP3R is
involved in PrP- and Aβ-induced apoptotic death.
Several studies have shown the involvement of ER stress in
neuronal death that occurs in PrD and AD and suggest that PrP and
Aβ peptides play a role in ER-mediated cell injury. In fact, Hetz et
al. (2003) refer that caspase-12 activation is detected in cells
treated with PrPSc and that GRP58, a chaperone with protein
disulfide isomerase (PDI)-like activity, protects cells against PrPSc
toxicity and decreases the rate of caspase-12 activation (Hetz et al.,
676 E. Ferreiro et al. / Neurobiology of Disease 23 (2006) 669–6782005). In addition, Nakagawa et al. (2000) point out that cortical
neurons deficient in caspase-12 are more resistant to Aβ protein
neurotoxicity. Furthermore, cells that express presenilin 1 mutants,
linked to familial AD, have increased susceptibility to ER stress
(Katayama et al., 2004; Imaizumi et al., 2001).
Our results show that PrP106–126 and Aβ1–40 induce the
increase of GRP78 levels and caspase-12 activation in cortical
neurons, indicating that these peptides induce ER stress, which can
be activated by the unfolded protein response (UPR) and by
disturbance of Ca2+ homeostasis (Kaufman, 1999). The balance
between intracellular Ca2+ levels and the ER Ca2+ content is
guaranteed by two different processes: the pumping in the ER by
SERCA ATPases and the release by the opening of IP3R or RyR
Ca2+ release channels (Berridge et al., 2000). These Ca2+ release
channels of the ER participate in the signal transduction pathway
of apoptosis (Guo et al., 1997; Jayaraman and Marks, 1997; Pan et
al., 2000). In agreement with results obtained by other authors
using PC12 cells (Guo et al., 1996, 1997), we have recently
demonstrated that Ca2+ release from RyR but also from IP3R is
involved in Aβ25–35 toxicity in cortical neurons (Ferreiro et al.,
2004). IP3-mediated Ca
2+ release from the ER was previously
demonstrated to trigger apoptosis in response to diverse signals
(Distelhorst and Roderick, 2003). It has been shown in our
laboratory that Aβ25–35/1–40 and PrP106–126 can induce the
increase of cytosolic Ca2+ levels in cortical neurons following 24 h
of incubation (Ferreiro et al., 2004; Agostinho and Oliveira, 2003).
In the present study, we show that in cortical neurons treated with
PrP106–126 and Aβ1–40 intracellular Ca2+ levels increase before
24 h of incubation. In fact, at 1 h of incubation, a significant rise in
cytosolic Ca2+ concentration was measured. The Ca2+ release
through the RyR and IP3R contributes to this early [Ca
2+]i increase.
Several studies indicate that, in addition to perturbed Ca2+
homeostasis, oxidative stress also occurs in PrD and AD (reviewed
in Brown et al., 1996; Agostinho and Oliveira, 2003; Fernaeus and
Land, 2005; Sheehan et al., 1997; Zhu et al., 2004). In fact, the ER
is especially vulnerable to oxidative stress since it is one of the cell
organelles that produce ROS (Hayashi et al., 2005). Furthermore,
oxidative stress may lead to perturbations of the ER Ca2+
homeostasis because many of the regulatory proteins of ER Ca2+,
such as IP3R and RyR, the Ca
2+ ATPases and the ER-resident
proteins, are sensitive to oxidants (Huang et al., 2004). In addition,
Ca2+ that results from the depletion of ER Ca2+ stores can be taken
up by juxtaposed mitochondria, inducing ROS formation (Tardif et
al., 2005). Our study demonstrates that PrP106–126 and Aβ1–40
induce ROS formation in cortical neurons, and this effect was
prevented by dantrolene and xestospongin C, indicating that Ca2+
release through RyR and IP3R is involved in PrP- and Aβ-induced
ROS formation. In the case of PrP106–126, the intracellular Ca2+
increase precedes the ROS formation, indicating that intracellular
Ca2+ rise is an early event in PrP peptide toxicity.
ER Ca2+ release has been shown to have immediate effects on
mitochondrial function, leading to rapid Ca2+ accumulation in
mitochondria which promotes cytochrome c release and activation
of downstream caspase pathways in cells exposed to proapoptotic
agents (Nutt et al., 2002). In the cytosol, cytochrome c binds Apaf-
1 and dATP to form a complex that activates caspase-9, which can
activate the executioner caspase-3 (Desagher and Martinou, 2000).
Cytochrome c has been shown to be involved in the neurotoxicity
of Aβ25–35 and PrP106–126 (Cardoso et al., 2002; Agostinho and
Oliveira, 2003). Our results show that, beyond the fact that Aβ and
PrP peptides induce cytochrome c release from mitochondria, ERCa2+ release through RyR and IP3R is involved in the process,
demonstrating that mitochondria and the ER cooperate in the
neuronal death induced by Aβ and PrP peptides. These results are
in agreement with data obtained in cells treated with ER stressors
in which ER/mitochondria crosstalk was demonstrated (Häcki et
al., 2000; Boya et al., 2002). Although our results demonstrate that
ER stress induced by PrP and Aβ peptides occurs upstream of
mitochondrial dysfunction, since cytochrome c release is prevented
by dantrolene and xestospongin C, we cannot rule out the
possibility that mitochondrial dysfunction could also trigger ER
stress, propagating the initial injury. Recently, it was demonstrated
that both full-length APP and Aβ accumulate in the mitochondria
compartment causing mitochondrial dysfunction (Anandatheertha-
varada et al., 2003; Lustbader et al., 2004), which may in turn
deregulate ER Ca2+ homeostasis. In fact, inhibition of mitochon-
drial respiratory chain with rotenone was shown to induce ER
stress through the phosphorylation of the key ER stress kinases
IRE1α and PKR-like ER kinase (PERK) (Ryu et al., 2002).
Several caspases have been shown to be involved in ER stress.
Hitomi et al. (2003) have shown that activation of caspase-12
indirectly activates cytoplasmic caspase-3 and activation of this
caspase is completely suppressed in cells overexpressing Bcl-2
targeted specifically to the ER (Häcki et al., 2000). Dahmer (2005)
has shown that thapsigargin, an activator of ER stress, induces
activation of the caspase-2, -3 and -7. He et al. (2002) had already
shown that thapsigargin-mediated perturbation in Ca2+ home-
ostasis upregulates DR5 (death receptor 5) and TRAIL (tumor
necrosis factor-related apoptosis inducing ligand), and this is
coupled with caspase-8 activation and Bid cleavage. In the present
study, it was demonstrated that caspase-2, -3, -6, -8 and -9
activities are increased upon exposure to PrP106–126 and Aβ1–40.
Also under our experimental conditions, the caspase-3 activity
increased upon treatment with PrP 106–126 and Aβ1–40 was
prevented by the ER Ca2+ release inhibitors dantrolene and
xestospongin C, suggesting that perturbation of ER Ca2+ home-
ostasis mediated by Ca2+ release from RyR and IP3R is involved in
the activation of caspase-3 induced by the peptides.
One possible site of initiation of apoptosis is the synapse.
Perturbed synaptic ER Ca2+ homeostasis promotes activation of
apoptotic cascades (Mattson, 2000). Therefore, since PrP and
Aβ peptides are known to be produced and to accumulate in high
amounts at the synapses (Gong et al., 2003; Sales et al., 1998;
Herms et al., 1999), our results support the view that loss of ER
Ca2+ homeostasis induced by the peptides is involved in synaptic
dysfunction and loss of dendritic spines, which are early events
that occur in PrD and AD (Belichenko et al., 2000; Selkoe, 2002).
Furthermore, perturbation of Ca2+ homeostasis induced by these
peptides can lead to the activation of several kinases, such as GSK-
3 and Cdk5, and to the consequent phosphorylation of the
microtubule-associated protein tau, leading to the formation of
neurofibrillary tangles (Pérez et al., 2003; Lee et al., 2000;
reviewed in Fuentalba et al., 2004). Therefore, the ER stress
induced by PrP and Aβ in the early stages of the diseases, in which
they are implicated, may be associated with synaptic loss and with
the presence of neurofibrillary tangles, central hallmarks of AD
that may be also related to PrD. We then suggest that drugs that
stabilize neuronal Ca2+ homeostasis, including dantrolene and
xestospongin C to suppress Ca2+ release from ER, are potential
therapeutical targets for PrD and AD.
Altogether, our in vitro results show that PrP106–126 and Aβ1–
40 induce Ca2+ homeostasis deregulation, oxidative stress and
677E. Ferreiro et al. / Neurobiology of Disease 23 (2006) 669–678apoptotic cell death by a mechanism that involves the early release
of Ca2+ from ER through RyR and IP3R. Furthermore, the results
presented here demonstrate that PrP- and Aβ-induced Ca2+ release
from ER leads to mitochondrion-mediated cell death, suggesting
that both organelles cooperate in PrP- and Aβ-induced apoptosis.Acknowledgments
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